These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1331974)

  • 1. The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid.
    Brinkmeier H; Wollinsky KH; Hülser PJ; Seewald MJ; Mehrkens HH; Kornhuber HH; Rüdel R
    Pflugers Arch; 1992 Sep; 421(6):552-7. PubMed ID: 1331974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels.
    Würz A; Brinkmeier H; Wollinsky KH; Mehrkens HH; Kornhuber HH; Rüdel R
    Muscle Nerve; 1995 Jul; 18(7):772-81. PubMed ID: 7783768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome).
    Wollinsky KH; Hülser PJ; Brinkmeier H; Mehrkens HH; Kornhuber HH; Rüdel R
    Ann Med Interne (Paris); 1994; 145(7):451-8. PubMed ID: 7864511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquorpheresis eliminates blocking factors from cerebrospinal fluid in polyradiculoneuritis (Guillain-Barré syndrome).
    Hülser PJ; Wiethölter H; Wollinsky KH
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):69-72. PubMed ID: 1834186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small sodium channel blocking factor in the cerebrospinal fluid is preferentially found in Guillain-Barré syndrome: a combined cell physiological and HPLC study.
    Weber F; Brinkmeier H; Aulkemeyer P; Wollinsky KH; Rüdel R
    J Neurol; 1999 Oct; 246(10):955-60. PubMed ID: 10552246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquorpheresis (CSF-filtration): an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome).
    Wollinsky KH; Weindler M; Hülser PJ; Geiger P; Matzek N; Mehrkens HH; Kornhuber HH
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):73-6. PubMed ID: 1834187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the nature of endogenous antiexcitatory factors in the cerebrospinal fluid of patients with demyelinating neurological disease.
    Brinkmeier H; Seewald MJ; Wollinsky KH; Rüdel R
    Muscle Nerve; 1996 Jan; 19(1):54-62. PubMed ID: 8538670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels.
    Brinkmeier H; Wollinsky KH; Seewald MJ; Hülser PJ; Mehrkens HH; Kornhuber HH; Rüdel R
    Neurosci Lett; 1993 Jun; 156(1-2):172-5. PubMed ID: 8414183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human endogenous local anesthetic-like factor (ELLF) is functionally neutralized by serum albumin.
    Aulkemeyer P; Brinkmeier H; Wollinsky KH; Rüdel R
    Neurosci Lett; 1996 Sep; 216(1):37-40. PubMed ID: 8892386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Guillain-Barré syndrome. Clinical and laboratory features.
    Grand'Maison F; Feasby TE; Hahn AF; Koopman WJ
    Brain; 1992 Aug; 115 ( Pt 4)():1093-106. PubMed ID: 1393505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
    Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
    Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C.
    Bendahhou S; Cummins TR; Potts JF; Tong J; Agnew WS
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12003-7. PubMed ID: 8618832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome.
    Corston RN; McGale EH; Stonier C; Aber GM; Hutchinson EC
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):86-9. PubMed ID: 7205311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of the Guillain-Barré syndrome.
    Soffer D; Feldman S; Alter M
    J Neurol Sci; 1978 Jun; 37(1-2):135-43. PubMed ID: 690663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current diagnostic criteria for Guillain-Barré syndrome.
    van der Meché FG; Meulstee J; Kleyweg RP
    Ann Neurol; 1991 Dec; 30(6):851-2. PubMed ID: 1789699
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP.
    Sivieri S; Ferrarini AM; Lolli F; Matà S; Pinto F; Tavolato B; Gallo P
    J Neurol Sci; 1997 Mar; 147(1):93-5. PubMed ID: 9094066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CSF filtration and interferon-beta for Guillain-Barré syndrome].
    Odaka M
    Nihon Rinsho; 2008 Jun; 66(6):1200-4. PubMed ID: 18540371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.